Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The most commonly reported side effects of this medication affect the digestive system and often occur when treatment is started or the dose is increased
Bettadapura et al., 2024
The combination of GIP and GLP-1 activation explains why dual-receptor agonists like tirzepatide outperform single-receptor GLP-1 drugs
Effective medication for lasting weight loss and/or reduced calorie diet and increased physical activity Lose 16.9% body weight in 68 weeks Lose 24.3% body weight in 72 weeks Enter your height and weight below Because your goals deserve more than promises - they deserve results
This dual action is a key benefit of Ipamorelin and an important factor in changing body composition, especially during periods of weight loss
May cause discomfort and increase preterm labour risk
